Health
SARS-CoV-2 can disrupt the blood-brain barrier, find scientists – Drug Target Review
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.
Posted: 2 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Binding of SARS-CoV-2 spike proteins to the brains endothelial cells can cause the blood-brain barrier to become leaky, potentially causing the neurological symptoms associated with COVID-19.
While the causes of respiratory symptoms related to SARS-CoV-2 infection have been well studied, the vascular and neurological symptoms are more poorly understood.
In the case of respiratory symptoms, it is known that entry of the…
-
Business24 hours agoWhy this fantastic blue chip ASX 200 share could rise 20%
-
General23 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
Noosa News14 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
General16 hours agoPhotographers reveal iconic image of Gough Whitlam and Vincent Lingiari was posed on Wave Hill Walk-Off anniversary